Literature DB >> 9230251

Effects of psychotherapy in moderately severe COPD: a pilot study.

N Eiser1, C West, S Evans, A Jeffers, F Quirk.   

Abstract

Anxiety is common in the "pink puffer" syndrome associated with chronic obstructive pulmonary disease (COPD). The degree of anxiety correlates well with perceived dyspnoea. This pilot study examines the effect of group psychotherapy on anxiety, exercise tolerance, dyspnoea and quality of life. Ten patients with moderately severe, stable COPD (mean forced expiratory volume in one second (FEV1)-1.15 L) had six 90 min sessions of cognitive and behavioural psychotherapy at weekly intervals. Patients completed the Hospital Anxiety and Depression Scale (HADS), Medical Research Council Questionnaire (MRCQ) and St George's Respiratory Questionnaires (SGRQ), 1 week before and after therapy. FEV1, forced vital capacity (FVC), slow vital capacity (SVC), blood gas tensions and 6 min walking distance (6MWD) were measured. Eight control patients attended weekly for lung function and 6MWD for 6 weeks, but had no psychotherapy. Mean baseline HADS score was significantly higher in the psychotherapy group (12) than in controls (7), but otherwise there were no differences in lung function, blood gas tensions, 6MWD, or the other questionnaire scores between groups. After treatment, the physiological and psychological parameters where unchanged in both groups with the exception of the mean 6MWD, which had improved in the psychotherapy group only, from 351 to 423 m (p<0.001), an increase of 24%. Three months after treatment, the 6MWD was still 16% above the baseline value (p=0.02). In conclusion, six sessions of cognitive and behavioural psychotherapy produced a sustained improvement in exercise tolerance in a group of 10 anxious patients with severe chronic obstructive pulmonary disease, without any change in anxiety scores on the Hospital Anxiety and Depression Scale. Further studies of more prolonged, intensive psychotherapy would establish whether better symptom and quality of life scores accompany more dramatic increases in exercise tolerance in "pink puffers".

Entities:  

Mesh:

Year:  1997        PMID: 9230251     DOI: 10.1183/09031936.97.10071581

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

Review 1.  Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.

Authors:  Darcy D Marciniuk; Donna Goodridge; Paul Hernandez; Graeme Rocker; Meyer Balter; Pat Bailey; Gord Ford; Jean Bourbeau; Denis E O'Donnell; Francois Maltais; Richard A Mularski; Andrew J Cave; Irvin Mayers; Vicki Kennedy; Thomas K Oliver; Candice Brown
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

Review 2.  WITHDRAWN: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  Claudia Bausewein; Sara Booth; Marjolein Gysels; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

3.  Depression Treatment Among Elderly Medicare Beneficiaries With Incident Cases of Cancer and Newly Diagnosed Depression.

Authors:  Monira Alwhaibi; Suresh Madhavan; Thomas Bias; Kimberly Kelly; Jamie Walkup; Usha Sambamoorthi
Journal:  Psychiatr Serv       Date:  2017-01-03       Impact factor: 3.084

Review 4.  Mood disorders and chronic obstructive pulmonary disease: current research and future needs.

Authors:  Greg L Clary; Scott M Palmer; P Murali Doraiswamy
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

5.  Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease.

Authors:  Rebecca E Schane; Louise C Walter; Alexis Dinno; Ken E Covinsky; Prescott G Woodruff
Journal:  J Gen Intern Med       Date:  2008-08-09       Impact factor: 5.128

Review 6.  Anxiety and depression in COPD: current understanding, unanswered questions, and research needs.

Authors:  Janet Maurer; Venkata Rebbapragada; Soo Borson; Roger Goldstein; Mark E Kunik; Abebaw M Yohannes; Nicola A Hanania
Journal:  Chest       Date:  2008-10       Impact factor: 9.410

7.  Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease.

Authors:  Tina Phan; Owen Carter; Claire Adams; Grant Waterer; Li Ping Chung; Maxine Hawkins; Cobie Rudd; Mel Ziman; Natalie Strobel
Journal:  Chron Respir Dis       Date:  2016-03-03       Impact factor: 2.444

Review 8.  A review of cognitive behavioral therapy for panic disorder in patients with chronic obstructive pulmonary disease: the rationale for interoceptive exposure.

Authors:  Terri L Barrera; Kathleen M Grubbs; Mark E Kunik; Ellen J Teng
Journal:  J Clin Psychol Med Settings       Date:  2014-06

Review 9.  Depression in COPD--management and quality of life considerations.

Authors:  Kurt B Stage; Thomas Middelboe; Tore B Stage; Claus H Sørensen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients.

Authors:  Athanasios Tselebis; Dionisios Bratis; Argiro Pachi; Georgios Moussas; Ioannis Ilias; Maria Harikiopoulou; Elpida Theodorakopoulou; Silvia Dumitru; Epaminondas Kosmas; Alexandros Vgontzas; Nikolaos Siafakas; Nikolaos Tzanakis
Journal:  Multidiscip Respir Med       Date:  2013-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.